STRS Ohio’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

STRS Ohio’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-192,700	Closed	-$439K	–	2093
2024 Q2	$439K	Buy	+192,700	New	+$736K	﹤0.01%	1314
2019 Q1	–	Sell	-4,100	Closed	-$78K	–	2117
2018 Q4	$78K	Hold	4,100	–	–	﹤0.01%	1808
2018 Q3	$214K	Hold	4,100	–	–	﹤0.01%	1704
2018 Q2	$178K	Buy	4,100 +1,800	+78%	+$77.1K	﹤0.01%	1773
2018 Q1	$85K	Hold	2,300	–	–	﹤0.01%	1652
2017 Q4	$45K	Hold	2,300	–	–	﹤0.01%	1762
2017 Q3	$57K	Buy	+2,300	New	+$42.5K	﹤0.01%	1762

STRS Ohio's GTHX Position: Q3 2024 in Review

STRS Ohio sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 192,700 shares — an estimated $439K sold.

STRS Ohio first reported a position in GTHX in Q3 2017 and held it in 7 quarters. The position peaked at $439K in Q2 2024. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

STRS Ohio reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
STRS Ohio sold 192,700 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $439K.
STRS Ohio first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2017 and held it in 7 quarters.
STRS Ohio's G1 Therapeutics, Inc. Common Stock position peaked at $439K in Q2 2024.
0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on STRS Ohio's 13F filing for Q3 2024, filed 1 Nov 2024.